Literature DB >> 33231840

Protective effects of mesenchymal stem cells on ischemic brain injury: therapeutic perspectives of regenerative medicine.

Saeid Bagheri-Mohammadi1,2,3.   

Abstract

Cerebral ischemic injury as the main manifestation of stroke can occur in stroke patients (70-80%). Nowadays, the main therapeutic strategy used for ischemic brain injury treatment aims to achieve reperfusion, neuroprotection, and neurorecovery. Also, angiogenesis as a therapeutic approach maybe represents a promising tool to enhance the prognosis of cerebral ischemic stroke. Unfortunately, although many therapeutic approaches as a life-saving gateway for cerebral ischemic injuries like pharmacotherapy and surgical treatments are widely used, they all fail to restore or regenerate damaged neurons in the brain. So, the suitable therapeutic approach would focus on regenerating the lost cells and restore the normal function of the brain. Currently, stem cell-based regenerative medicine introduced a new paradigm approach in cerebral ischemic injuries treatment. Today, in experimental researches, different types of stem cells such as mesenchymal stem cells have been applied. Therefore, stem cell-based regenerative medicine provides the opportunity to inquire and develop a more effective and safer therapeutic approach with the capability to produce and regenerate new neurons in damaged tissues.

Entities:  

Keywords:  Cell therapy; Cerebral ischemia; Mesenchymal stem cells; Regenerative medicine; Stem cells

Year:  2020        PMID: 33231840     DOI: 10.1007/s10561-020-09885-6

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  49 in total

1.  Ischemic stroke activates hematopoietic bone marrow stem cells.

Authors:  Gabriel Courties; Fanny Herisson; Hendrik B Sager; Timo Heidt; Yuxiang Ye; Ying Wei; Yuan Sun; Nicolas Severe; Partha Dutta; Jennifer Scharff; David T Scadden; Ralph Weissleder; Filip K Swirski; Michael A Moskowitz; Matthias Nahrendorf
Journal:  Circ Res       Date:  2014-10-31       Impact factor: 17.367

Review 2.  Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy.

Authors:  Ivana Antonucci; Andrea Pantalone; Stefano Tete; Vincenzo Salini; Cesar V Borlongan; David Hess; Liborio Stuppia
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Clinical Translation of Stem Cells for Regenerative Medicine.

Authors:  Deepa Bhartiya
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

Review 4.  Hierarchical organization of fetal and adult hematopoietic stem cells.

Authors:  Sonja Babovic; Connie J Eaves
Journal:  Exp Cell Res       Date:  2014-08-13       Impact factor: 3.905

Review 5.  Stem cell-based therapy for Parkinson's disease with a focus on human endometrium-derived mesenchymal stem cells.

Authors:  Saeid Bagheri-Mohammadi; Mohammad Karimian; Behrang Alani; Javad Verdi; Rana Moradian Tehrani; Mahdi Noureddini
Journal:  J Cell Physiol       Date:  2018-08-26       Impact factor: 6.384

6.  Exosome and Microvesicle-Enriched Fractions Isolated from Mesenchymal Stem Cells by Gradient Separation Showed Different Molecular Signatures and Functions on Renal Tubular Epithelial Cells.

Authors:  Federica Collino; Margherita Pomatto; Stefania Bruno; Rafael Soares Lindoso; Marta Tapparo; Wen Sicheng; Peter Quesenberry; Giovanni Camussi
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

7.  Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury.

Authors:  Brooke Bonsack; Sydney Corey; Alex Shear; Matt Heyck; Blaise Cozene; Nadia Sadanandan; Henry Zhang; Bella Gonzales-Portillo; Michael Sheyner; Cesar V Borlongan
Journal:  CNS Neurosci Ther       Date:  2020-05-01       Impact factor: 5.243

8.  Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation.

Authors:  Mohsen Abbasi-Kangevari; Seyyed-Hadi Ghamari; Fahimeh Safaeinejad; Soheyl Bahrami; Hassan Niknejad
Journal:  Front Immunol       Date:  2019-02-20       Impact factor: 7.561

Review 9.  Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment.

Authors:  Héctor Fernández-Susavila; Ana Bugallo-Casal; José Castillo; Francisco Campos
Journal:  Front Neurol       Date:  2019-08-28       Impact factor: 4.003

Review 10.  Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet?

Authors:  Cesario V Borlongan
Journal:  Stem Cells Transl Med       Date:  2019-05-16       Impact factor: 6.940

View more
  4 in total

Review 1.  Adult stem cell transplantation combined with conventional therapy for the treatment of end-stage liver disease: a systematic review and meta-analysis.

Authors:  Chen-Hui Zhu; Dian-Han Zhang; Chen-Wei Zhu; Jing Xu; Chuan-Long Guo; Xiang-Gen Wu; Qi-Long Cao; Guo-Hu Di
Journal:  Stem Cell Res Ther       Date:  2021-10-30       Impact factor: 6.832

2.  FNDC5 overexpression promotes the survival rate of bone marrow mesenchymal stem cells after transplantation in a rat cerebral infarction model.

Authors:  Huan Wei; Kangmei Liu; Tingting Wang; Yanping Li; Shaolei Guo; Ling Li
Journal:  Ann Transl Med       Date:  2022-01

Review 3.  C1q/Tumor Necrosis Factor-Related Protein 9: Basics and Therapeutic Potentials.

Authors:  Hua Guan; Yanli Wang; Xiangyu Li; Aoqi Xiang; Fengwei Guo; Jianglin Fan; Qi Yu
Journal:  Front Physiol       Date:  2022-03-18       Impact factor: 4.566

Review 4.  Adult Hippocampal Neurogenesis and Alzheimer's Disease: Novel Application of Mesenchymal Stem Cells and their Role in Hippocampal Neurogenesis.

Authors:  Mahdi Noureddini; Saeid Bagheri-Mohammadi
Journal:  Int J Mol Cell Med       Date:  2021-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.